Westside Investment Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440 | Hold |
200
| – | – | ﹤0.01% | 1258 |
|
|
2025
Q1 | $232 | Sell |
200
-1,350
| -87% | -$1.57K | ﹤0.01% | 961 |
|
|
2024
Q4 | $1.97K | Hold |
1,550
| – | – | ﹤0.01% | 903 |
|
|
2024
Q3 | $5.63K | Hold |
1,550
| – | – | ﹤0.01% | 760 |
|
|
2024
Q2 | $7.24K | Sell |
1,550
-300
| -16% | -$1.4K | ﹤0.01% | 705 |
|
|
2024
Q1 | $13.7K | Hold |
1,850
| – | – | ﹤0.01% | 574 |
|
|
2023
Q4 | $18.7K | Hold |
1,850
| – | – | ﹤0.01% | 504 |
|
|
2023
Q3 | $14.4K | Hold |
1,850
| – | – | ﹤0.01% | 530 |
|
|
2023
Q2 | $15.2K | Hold |
1,850
| – | – | ﹤0.01% | 521 |
|
|
2023
Q1 | $13.4K | Hold |
1,850
| – | – | ﹤0.01% | 537 |
|
|
2022
Q4 | $1.7K | Hold |
1,850
| – | – | ﹤0.01% | 239 |
|
|
2022
Q3 | $2.47K | Sell |
1,850
-300
| -14% | -$400 | 0.01% | 234 |
|
|
2022
Q2 | $4.07K | Hold |
2,150
| – | – | 0.01% | 216 |
|
|
2022
Q1 | $4.08K | Hold |
2,150
| – | – | 0.01% | 216 |
|
|
2021
Q4 | $8.03K | Hold |
2,150
| – | – | 0.02% | 194 |
|
|
2021
Q3 | $8.06K | Sell |
2,150
-1,300
| -38% | -$4.88K | 0.02% | 194 |
|
|
2021
Q2 | $17.2K | Sell |
3,450
-200
| -5% | -$995 | 0.04% | 163 |
|
|
2021
Q1 | $12.7K | Sell |
3,650
-100
| -3% | -$349 | 0.03% | 165 |
|
|
2020
Q4 | $21.3K | Buy |
3,750
+250
| +7% | +$1.42K | 0.06% | 132 |
|
|
2020
Q3 | $19.7K | Sell |
3,500
-100
| -3% | -$563 | 0.01% | 130 |
|
|
2020
Q2 | $20.8K | Sell |
3,600
-11,088
| -75% | -$64K | 0.01% | 107 |
|
|
2020
Q1 | $106K | Buy |
+14,688
| New | +$106K | 0.07% | 50 |
|